The Dutch Institute
Autor Wim Huppesen Limba Engleză Paperback – 29 iun 2022
Dr. Marten Keyser has incurable cancer. With nothing to lose he survives by pursuing a drug regime of his own devising. Already unpopular with the powerbrokers in the dystopian healthcare system, he then develops a light-based therapy, but his low-cost innovation threatens the power balance and a cat-and-mouse game of survival ensues. In the face of mounting intrigue aggravated by the Coronavirus pandemic, Marten and his wife delve into high-level corruption, struggle to save their relationship, and build new alliances that might offer them a safe future.
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (2) | 96.06 lei 3-5 săpt. | |
austin macauley publishers llc – 29 iun 2022 | 96.06 lei 3-5 săpt. | |
HUGO PUBLISHING – 25 noi 2019 | 129.78 lei 6-8 săpt. |
Preț: 96.06 lei
Nou
Puncte Express: 144
Preț estimativ în valută:
18.39€ • 19.15$ • 15.26£
18.39€ • 19.15$ • 15.26£
Carte disponibilă
Livrare economică 23 ianuarie-06 februarie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781398448940
ISBN-10: 139844894X
Pagini: 268
Dimensiuni: 156 x 234 x 14 mm
Greutate: 0.38 kg
Editura: austin macauley publishers llc
ISBN-10: 139844894X
Pagini: 268
Dimensiuni: 156 x 234 x 14 mm
Greutate: 0.38 kg
Editura: austin macauley publishers llc
Notă biografică
For forty years Wim Huppes was an insider with intimate knowledge of the corridors of power. This book could only be written when Wim himself had nothing to lose, havingbeen given up with incurable cancer. In pursuitof a cure in turbulent times of the Corona pandemic, he was intimidated, arrested on severaloccasions and his medicines, instruments and paperwork was confiscated. His experience informed this work of fiction. His professional background includes:
Internist with annotation oncology - UtrechtUniversity
PhD thesis in biotechnology - VU University Amsterdam
Representativeat the European Medicines Agency
Internist with annotation oncology - UtrechtUniversity
PhD thesis in biotechnology - VU University Amsterdam
Representativeat the European Medicines Agency